2010 Annual Meeting

Session: Applications of Multivariate Data Analysis in Pharmaceutical Process Development

The quality by design paradigm has rapidly increased the adoption of multivariate data analysis in Pharmaceutical Development. The application of these powerful techniques on experimental, process, or PAT data can result in significant increases of development productivity and substantial reduction of process risk. Authors are encouraged to submit papers discussing case studies in which multivariate data analysis was applied to increase process understanding to improve process robustness and performance or decrease development time.

Chair

Sze Wing Wong, Eli Lilly and Company

Co-Chair

Jose E. Tabora, Bristol Myers Squibb

Presentations

12:30 PM

Salvador Garcia-Munoz, Jose Mercado, Israel Cotto, Victor Ruiz, Ivelisse Colon-Rivera, Denise Rivkees, Josh Shockey, Matt Shaffer, Leah Appel

12:45 PM

Jose E. Tabora, James Bergum, Victor Rosso, Amanda Rogers, Jacob Albrecht

01:10 PM

01:50 PM

02:10 PM

02:30 PM

Haigang Wang, Lubomir Gradinarsky, Staffan Folestad, Proctor Ian, Wuqiang Yang